Glucocerebrosidase mutations in diffuse Lewy body disease

  • Kenya Nishioka
  • , Owen A. Ross
  • , Carles Vilariño-Güell
  • , Stephanie A. Cobb
  • , Jennifer M. Kachergus
  • , David M.A. Mann
  • , Julie Snowden
  • , Anna M.T. Richardson
  • , David Neary
  • , Christopher A. Robinson
  • , Alex Rajput
  • , Spiridon Papapetropoulos
  • , Deborah C. Mash
  • , Rajesh Pahwa
  • , Kelly E. Lyons
  • , Zbigniew K. Wszolek
  • , Dennis W. Dickson
  • , Matthew J. Farrer

Research output: Contribution to journalArticlepeer-review

Abstract

Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson's disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body disease. Taken with previous studies, it appears that GBA mutations are associated with a more diffuse pattern of Lewy body distribution involving the cerebral cortex than the brainstem/limbic distribution observed in typical Parkinson's disease.

Original languageEnglish
Pages (from-to)55-57
Number of pages3
JournalParkinsonism and Related Disorders
Volume17
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

ASJC Scopus Subject Areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Keywords

  • DLBD
  • Gaucher disease
  • GBA
  • Genetics

Fingerprint

Dive into the research topics of 'Glucocerebrosidase mutations in diffuse Lewy body disease'. Together they form a unique fingerprint.

Cite this